NCT06545565View on ClinicalTrials.gov

Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutrition

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

May 10, 2025

Study Completion Date

May 10, 2025

Conditions
Metabolic AcidosisNeonatal DiseaseNeonatal Complication
Interventions
DRUG

sodium acetate group will receive sodium acetate in the neonatal PN.

This group will receive sterile sodium acetate daily in the neonatal PN for the duration the patient will receive parenteral nutrition, a maximum of 28 days of life.

DRUG

sodium chloride group will receive sodium chloride in the neonatal PN.

This group will receive sterile sodium chloride daily in the neonatal PN for the duration the patient will receive parenteral nutrition, a maximum of 28 days of life.

Trial Locations (1)

74800

RECRUITING

Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University Hospital, Pakistan

OTHER